I agree that this site is using cookies. You can find further informations here.
X
Kuchimanchi, Mita
23  results:
Search for persons X
?
1

Dostarlimab, an anti‐programmed death‐1 monoclonal antibody..:

Kuchimanchi, Mita ; Dabrowski, Christine ; Lu, Sharon.
British Journal of Clinical Pharmacology.  89 (2023)  7 - p. 2272-2282 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Model‐based meta‐analysis of non‐small cell lung cancer wit..:

Turner, David C. ; Wada, Russ ; Zhou, Helen...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  11 - p. 1751-1763 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Development of a Population Pharmacokinetic Model for the D..:

Kuchimanchi, Mita ; Bockbrader, Howard ; Dolphin, Nancy...
Neurology and Therapy.  11 (2022)  1 - p. 353-371 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Phase II Dose Selection for Alpha Synuclein–Targeting Antib..:

Kuchimanchi, Mita ; Monine, Michael ; Kandadi Muralidharan, Kumar..
CPT: Pharmacometrics & Systems Pharmacology.  9 (2020)  9 - p. 515-522 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Exposure–response analysis of blinatumomab in patients with..:

Kuchimanchi, Mita ; Zhu, Min ; Clements, John D..
British Journal of Clinical Pharmacology.  85 (2019)  4 - p. 807-817 , 2019
Link: https://doi.org/10.1111/..
 
?
6

Population Pharmacokinetics of Blinatumomab in Pediatric an..:

Clements, John David ; Zhu, Min ; Kuchimanchi, Mita..
Clinical Pharmacokinetics.  59 (2019)  4 - p. 463-474 , 2019
Link: https://doi.org/10.1007/..
 
?
7

Population pharmacokinetics and exposure–response modeling ..:

Kuchimanchi, Mita ; Grover, Anita ; Emery, Maurice G....
Journal of Pharmacokinetics and Pharmacodynamics.  45 (2018)  3 - p. 505-522 , 2018
Link: https://doi.org/10.1007/..
 
?
8

Assessment of pharmacokinetic interaction between rilotumum..:

Zhang, Yilong ; Kuchimanchi, Mita ; Zhu, Min...
British Journal of Clinical Pharmacology.  83 (2016)  5 - p. 1048-1055 , 2016
Link: https://doi.org/10.1111/..
 
?
9

Impact of Target‐Mediated Elimination on the Dose and Regim..:

Gibbs, John P. ; Doshi, Sameer ; Kuchimanchi, Mita...
The Journal of Clinical Pharmacology.  57 (2016)  5 - p. 616-626 , 2016
Link: https://doi.org/10.1002/..
 
?
10

Population pharmacokinetics analysis of AMG 416, an alloste..:

Chen, Ping ; Melhem, Murad ; Xiao, Jim..
The Journal of Clinical Pharmacology.  55 (2015)  6 - p. 620-628 , 2015
Link: https://doi.org/10.1002/..
 
?
11

FLT3 and CDK4/6 inhibitors: Signaling mechanisms and tumor ..:

Zhang, Yaping ; Hsu, Cheng-Pang ; Lu, Jian-Feng...
Journal of Pharmacokinetics and Pharmacodynamics.  41 (2014)  6 - p. 675-691 , 2014
Link: https://doi.org/10.1007/..
 
?
12

Differential Pharmacokinetics of Ganitumab in Patients With..:

Zhu, Min ; Gosselin, Nathalie H. ; Kuchimanchi, Mita...
Clinical Pharmacology in Drug Development.  2 (2013)  4 - p. 367-378 , 2013
Link: https://doi.org/10.1002/..
 
?
13

Exposure–response relationship of AMG 386 in combination wi..:

Lu, Jian-Feng ; Rasmussen, Erik ; Karlan, Beth Y....
Cancer Chemotherapy and Pharmacology.  69 (2012)  5 - p. 1135-1144 , 2012
Link: https://doi.org/10.1007/..
 
?
14

Population pharmacokinetic/pharmacodynamic modeling for the..:

Lu, Jian-Feng ; Claret, Laurent ; Sutjandra, Liviawati...
Cancer Chemotherapy and Pharmacology.  66 (2010)  6 - p. 1151-1158 , 2010
Link: https://doi.org/10.1007/..
 
?
15

Development of a Population Pharmacokinetic Model for the D..:

Kuchimanchi, Mita ; Bockbrader, Howard ; Dolphin, Nancy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857385/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15